The gene encoding the promyelocytic leukemia protein (Pml) is a tumor suppressor that was originally identified at the breakpoint of the t(15;17) translocation found in acute promyelocytic leukemia 1, 2 . Pml is associated with a subnuclear structure known as the Pml nuclear body (Pml-NB), of which it is the essential component 3, 4 . Pml is a potent growth suppressor in both cell lines and primary cells and regulates the tumor suppressors p53 and pRb [5] [6] [7] [8] . Recent studies suggest that Pml also exerts its tumor suppressive function outside of the haemopoietic system [8] [9] [10] [11] . In particular, Pml expression is lost in human tumors of multiple histological origins, including tumors of the CNS such as medulloblastoma 8, 9 .
The correct regulation of cell-cycle progression has been shown to be essential during the development of the nervous system (reviewed in refs. [12] [13] [14] . In particular, the neural epithelium lying in the apical area of the developing neocortex gives rise to progenitors, postmitotic neurons and macroglia in a temporally and spatially controlled fashion (reviewed in refs. 12, 13) . How the balance between proliferation and differentiation of NPCs is maintained during early development and which are the main processes involved remains a central question in the field of neurodevelopment 14 .
Our work has revealed a previously unknown role for Pml in the nervous system. We found that Pml expression is restricted to NPCs of the developing neocortex. Pml loss caused an increase in the number of proliferating NPCs and skewed the composition of NPCs subtypes in the neocortex. This in turn resulted in an impairment of differentiation and an overall decrease in cortical thickness and brain size. Finally, we identified a previously unknown interaction between Pml and the protein phosphatase 1a (PP1a) in the developing neocortex, which affects the phosphorylation status of the tumor suppressor retinoblastoma. Taken together, our findings implicate Pml in the control of NPC proliferation and shed new light on the mechanisms regulating neurogenesis in the developing brain.
RESULTS

Pml is expressed in NPCs in the developing neocortex
As the role of Pml in the development of the nervous system has not yet been explored, we set out to determine its expression pattern, focusing on the developing neocortex. We carried out immunohistochemistry (IHC) on coronal sections from embryonic day 15 (E15) mouse brains using an antibody to Pml. Pml expression was confined to cells residing in the ventricular zone of the neocortex (Fig. 1a) , identified by the neural progenitor/stem cell (hereafter referred to as NPC) marker Nestin, whereas we detected no Pml staining in Pml -/-cortices ( Fig. 1a) . At the subcellular level, Pml presented a nuclear speckled distribution that is characteristic of Pml nuclear bodies (Pml-NBs; Fig. 1a ) 2, 4 .
Cortical NPCs divide to give rise to different types of differentiated cells, which in turn migrate radially to specific layers in the cortical plate, where they acquire the MAP2 marker (reviewed in ref. 12 ). MAP2-positive neurons did not express Pml (Fig. 1a) . Newly born, bIII-tubulin (bIIITub)-positive neurons in the ventricular zone/subventricular zone (SVZ) were also negative for Pml (Fig. 1b) . Postnatally, the ventricular zone undergoes a marked reduction in size and the number of NPCs decreases substantially 15 . At postnatal days 0 and 7 (P0 and P7), Pml expression was still confined to the ventricular zone/ SVZ zone and was absent from the cortical plate (Fig. 1c,d ). In addition, Pml was expressed in a restricted number of cells in the hippocampus ( Supplementary Fig. 1 online) . Overall, these findings indicate that Pml is expressed in NPCs in the ventricular zone/SVZ, but not in newborn or mature neurons.
Pml loss affects brain size and NPC proliferation In light of the restricted pattern of Pml expression in the ventricular zone, we set out to investigate its role in regulating NPCs function and corticogenesis. P0 brains were isolated from Pml +/+ , Pml +/-and Pml -/-mice (total n ¼ 32). At this stage, neurogenesis, which begins early in embryonic life, is complete 15 . Therefore, any major defect in the structural organization of the brain can be readily detected. To analyze whether brain size was affected by Pml loss, we measured the width and length of Pml +/+ , Pml +/-and Pml -/-brains (Fig. 2a) . Notably, we found that Pml -/-mice had smaller brains than Pml +/+ and Pml +/-mice, which were instead comparable (Fig. 2a) . We then analyzed serial coronal sections stained with haematoxylin and eosin and found that, although the overall organization of the brain did not appear to be affected in Pml -/-mice, the cerebral cortex was reduced in size (Fig. 2b) . Indeed, the overall thickness of the cortex wall was clearly diminished (Fig. 2c) . This effect was not solely restricted to the cortex, as the size of the hippocampus also appeared to be affected (Supplementary Fig. 1 ). Finally, analysis of serial coronal sections from haematoxylin and eosin-stained control and Pml -/-adult brains showed substantial, albeit more modest, differences in the thickness of the cortical wall, suggesting a degree of compensation at later stages (Fig. 2d,e) . Taken together, these findings indicate that Pml loss affects the size of the mouse brain and, in particular, of the developing neocortex.
A number of seminal studies have shown that correct cell-cycle regulation at the level of NPCs is critical for the development of the neocortex (reviewed in refs. [12] [13] [14] 16, 17) . Because Pml is known to act as a growth suppressor, we reasoned that its loss could affect proliferation of NPCs. First, we assessed the number of proliferating cells by IHC using antibodies to the antigen encoded by the Mki67 gene (Ki67) and the proliferating cell nuclear antigen (PCNA). We found an increase in Ki67-and PCNA-positive cells in Pml -/-cortices compared with Pml +/-cortices ( Fig. 3a and data not shown) . A similar increase was observed in Pml -/-mice at P0 and P7 ( Supplementary Fig. 2 online and data not shown). We then analyzed the number of mitotic cells using an antibody to the mitotic marker phosphohistone H3 (PH3). Mitotic nuclei are found in the apical side of the ventricular zone as a result of intrakinetic nuclear migration, whereas nuclei in the S phase of the cell cycle are positioned more basally 12, 13 . E15 Pml -/-cortices showed an increase in the number of PH3 apical mitoses (Fig. 3b) . To determine the number of cells in the S phase of the cell cycle, we used intraperitoneal administration of the thymidine analog bromodeoxyuridine (BrdU) into 15-d-pregnant females. After 1 h, embryos were recovered and labeled with antibody to BrdU, as well as with an antibody to bIIITub to identify the boundary between the ventricular zone and cortical plate. As expected, BrdU-labeled nuclei were located basally in the ventricular zone (Fig. 3c) . Pml -/-cortices presented an elevated number of cells in S phase, whereas nuclear positioning did not appear to be substantially affected (Fig. 3c) .
To further study the proliferation phenotype, we set out to analyze cell cycle exit in vivo, as the balance between cell cycle exit and re-entry is believed to regulate neurogenesis in the developing neocortex (reviewed in ref. 14) . To this end, we injected E15 pregnant females intraperitoneally with BrdU and determined the number of BrdUand Ki67-positive cells in Pml -/-and Pml -/-littermate embryos after 24 h. In this assay, BrdU-positive cells can be either positive (cycling) or negative (not cycling) for Ki67. BrdU-negative, Ki67-positive cells are proliferating cells that did not transit through S phase during the pulse. We found a twofold decrease in the number of BrdU-positive, Ki67-negative cells in Pml -/-cortices (Fig. 3d) . Furthermore, the number of Ki67-and BrdU-positive cells present in the Pml -/-ventricular zone was increased, suggesting that a larger portion of Pml -/-cells entered S phase (Fig. 3d) . Finally, we measured the levels of developmental cell death in the developing neocortex at E15 and found no differences between control and Pml -/-embryos ( Supplementary Fig. 3 online) .
Cell proliferation in two distinct types of NPCs, radially oriented radial glial cells (RGCs) and basally located intermediate progenitors, drives cortical expansion 16, 18 . Basally located intermediate progenitors originate from asymmetric divisions of RGCs, although the mechanisms controlling their genesis are still unclear. We set out to investigate whether Pml loss affects the transition between RGCs and basally located intermediate progenitors. The transcription factors Pax6 and Tbr2 can be used to identify these two major NPCs subtypes 16 . Notably, in Pml-deficient cortices, an increased number of Pax6-positive RGCs was accompanied by a reduction in the number of basally located intermediate progenitors, which were identified using the Tbr2 marker (Fig. 4a,b) 18, 19 . This result was further confirmed using the mitotic marker PH3, which identifies basally located intermediate progenitors undergoing basal mitosis in the ventricular zone (Fig. 4c) . Overall, these data demonstrate that the generation of basally located intermediate progenitors is reduced in the Pml -/-cortex.
Differentiation is impaired in the Pml -/-cortex
According to the models currently available, alterations in cell cycle exit and generation of basally located intermediate progenitors would affect corticogenesis 13, 14, 16, 18, [20] [21] [22] . Indeed, we revealed a significant decrease in the number of terminally differentiated MAP2-positive neurons at E15 (P ¼ 0.002; Fig. 5a ) and P0 (P ¼ 0.0028; Fig. 5b ) in the Pml -/-cortical plate. The mammalian neocortex is organized into multiple layers of mature neurons, which can be identified using specific markers 23 . Early-born neurons accumulate in deep layers and all of the subsequent waves of neurogenesis occur in an inside-out fashion 23 . To determine whether the layered structure of the cortex is affected in Pml -/-brains, we carried out IHC on P0 coronal sections using antibodies to Foxp2 and Foxp1, which identify deep layer 6 (Foxp2 positive) and layers 3, 4 and 5 (Foxp1 positive), respectively 24 . In the Pml -/-neocortex, Foxp1-and Foxp2-positive neurons were correctly positioned, albeit reduced in numbers, suggesting that neuronal specification is maintained ( Supplementary Fig. 4 online).
Then, we set out to determine whether generation of astrocytes (positive for glial fibrillary protein, GFAP) and oligodendrocytes (positive for MBP: Myelin Basic Protein positive) was also affected in the Pml -/-cerebral cortex, as assessed by IHC on sections from P7 brains. Notably, generation of macroglia was reduced in Pml -/-cortices, suggesting a broader effect of Pml loss on differentiation in the neocortex (Fig. 5c,d ).
Loss of Pml affects NPC function in vitro
To determine whether the effects of Pml loss on NPC proliferation and differentiation could be recapitulated in an in vitro system, we employed the neurosphere assay, which identifies NPCs according to their multipotency and self-renewal capacity 25, 26 . NPCs were isolated from Pml +/-and Pml -/-E12 littermate embryos and cultured for 10 d in vitro (DIV10) at a clonal density in the presence of epidermal growth factor and basic fibroblast growth factor (bFGF). The diameter of neurospheres from Pml -/-cortices was approximately twice that of the controls (Fig. 6a ) and the number of neurospheres was also increased (data not shown). We then analyzed the effect of Pml loss on differentiation using an in vitro differentiation assay, whereby NPC single-cell suspensions were induced to differentiate when plated at a high density in adherent conditions. The percentage of MAP2-positive cells (5 DIV) was significantly lower in Pml -/-cultures than in wild types, and, correspondingly, the percentage of Nestin-positive cells was higher ( Fig. 6b and Supplementary Fig. 5 online). Pml loss also affected the generation of oligodendrocytes and astrocytes, which are formed after neurogenesis is completed (10 DIV; Fig. 6b and Supplementary Fig. 5 ). Thus, the changes that we observed in Pml -/-embryos could be recapitulated in a cell culture system. We then performed rescue experiments using the PmlI isoform, which, together with PmlII is the most abundant isoform found in the mouse 27 . Reintroduction of PmlI in Pml -/-progenitors by retroviral infection caused a reduction in the diameter of neurospheres (Fig. 6c) . Pml exerts its growth-suppressive functions, at least in part, through its ability to assemble Pml-NBs, which relies on its modification by sumo ubiquitin-like modifier 1 (Sumo1) 4, 8 . Therefore, we investigated whether the effect on proliferation requires Pml Sumoylation and Pml-NB formation. We utilized a Pml mutant that lacked the three major Sumoylation sites (DSumo1-PmlI) in the neurosphere assays. DSumo1-PmlI failed to suppress proliferation in Pml-deficient NPCs (Fig. 6c) , suggesting that the formation of Pml-NBs is a prerequisite for PmlI's growth-suppressive ability in this context. Finally, reintroduction of PmlI also rescued the differentiation defect, while DSUMO-PmlI failed to do so (Fig. 6d) .
Pml regulates pRb localization and phosphorylation
Pml is known to control growth/tumor suppression by functionally interacting with other tumor-suppressive pathways 2, 8 . Among Pml interactors, pRb 6, [28] [29] [30] has an established role in nervous system development and the pathogenesis of brain tumors [31] [32] [33] [34] [35] [36] . pRb is a key factor in the control of the G1-S cell-cycle transition by binding to and inhibiting E2F transcription factors 32, 37 . However, pRb function at the level of NPCs is still unclear. We first analyzed the reciprocal localization patterns of Pml and pRb in the neocortex. IHC on E15 brain coronal sections using anti-Pml and anti-pRb antibodies revealed that pRb accumulates in nuclear speckles in the ventricular zone, which partially colocalize with Pml (Fig. 7a,b) . In contrast, pRb subcellular distribution was altered in Pml -/-NPCs, as it acquired a predominantly nucleoplasmic and cytoplasmic distribution (Fig. 7a,b) . A similar staining pattern was obtained using a different antibody to pRb ( Supplementary Fig. 6 online). These changes did not occur in the cortical plate, where Pml is normally not expressed, thus confirming the specificity of the observed alterations (Fig. 7a,b) . These results suggest that Pml regulates the subcellular localization of pRb in NPCs. Taking these findings into account, we set out to determine whether Pml and pRb interact in NPCs and carried out coimmunoprecipitation experiments using extracts from Pml +/-and Pml -/-NPCs. Indeed, pRb was found in Pml immunoprecipitates, whereas it was absent in pull-downs performed using extracts from Pml -/-NPCs (Fig. 7c) . Phosphorylation of pRb by the G1 cyclin-dependent kinases (Cdks) inhibits its E2F-binding capacity, and therefore its growthsuppressive properties 32, 37 . Because Pml has been shown to increase the levels of hypophosphorylated pRb in vitro 6,30 , we reasoned that it could also regulate pRb phosphorylation in NPCs. To test this, we analyzed the pRb phosphorylation status in extracts from Pml +/- and Pml -/-NPCs. In the absence of Pml, the amount of phosphorylated pRb was increased (Fig. 8a) .
Cyclin-dependent phosphorylation of pRb is counteracted by the activity of PP1a 38, 39 , which has been recently implicated in neocortex development 40 . We performed IHC on coronal sections from E15 Pml +/-and Pml -/-brains using antibodies to PP1a, pRb and Pml. PP1a was expressed throughout the neocortex and encompassed pRb expression domains (Fig. 8b) . At the subcellular level, pRb and PP1a formed partially overlapping speckled structures, which colocalized with Pml (Fig. 8c) . In the absence of Pml, PP1a was aberrantly expressed in the nucleoplasm and also acquired cytoplasmic staining, mirroring changes in the localization of pRb (Fig. 8c) . To determine whether Pml and PP1a interact, we performed co-immunoprecipitation experiments using extracts from proliferating Pml +/-and Pml -/-NPCs. Indeed, both pRb and PP1a were found in Pml immunoprecipitates, suggesting that the three proteins formed a nuclear complex (Fig. 8d) . Finally, Pml partially colocalized with PP1a and pRb in proliferating Pml +/-NPCs in vitro. In contrast, PP1a and pRb were aberrantly localized in Pml -/-NPCs (Fig. 8e) . Reintroduction of the PmlI isoform in Pml -/-NPCs restored the accumulation of both PP1a Immunoprecipitates were probed with antibodies to pRb, Pml and PP1a. Inputs are also shown. (e) Immunofluorescence of Pml +/-and Pml -/-NPCs stained with antibodies to Pml (red), pRb (green) and PP1a (purple). Nuclei were stained with DAPI. Scale bars represent 5 mm. (f) PmlI, but not DSumo1-PmlI, expression reduced pRb phosphorylation in Pml-deficient NPCs. Hyperand hypophosphorylated forms of pRb, as well as Pml and PP1a, were analyzed using an antibody to pRb in extracts from Pml -/-NPCs that were uninfected or infected with pBabe, pBabe-PmlI and DSumo1-PmlI-pBabe viruses.
and pRb into Pml-NBs and resulted in decreased pRb phosphorylation ( Supplementary Fig. 6 and Fig. 8f ). In contrast, the DSumo1-PmlI mutant failed to affect either pRb phosphorylation or its localization to Pml-NBs (Fig. 8f and data not shown) . Finally, the effect by PmlI on pRb phosphorylation was completely abolished in the presence of the PP1a inhibitor tautomycetin (Supplementary Fig. 6 ). Altogether, these findings support a model by which Pml regulates pRb in NPCs by promoting its PP1a-dependent dephosphorylation.
DISCUSSION
How the proliferation and maintenance of the NPC pool are controlled during neocortex development remains an important question in the field of neuroscience [12] [13] [14] 41 . Corticogenesis is tightly dependent on precise cell-cycle regulation to produce the correct number of mature neurons and macroglia in a temporally and spatially regulated fashion [12] [13] [14] 41 . Despite a number of advances in our understanding of this process, the identity of the primary regulators of cell cycle during corticogenesis remains unclear.
An unexpected role of Pml in regulating NPC function Disruption of the Pml gene results in defective myeloid development 42, 43 and increased tumor susceptibility on treatment with carcinogens 42 . In vitro, Pml has been shown to control cell proliferation, apoptosis and senescence 6, 8, 44 . However, the physiological role of Pml in the development and homeostasis of tissues outside of the haemopoietic compartment is still unclear. Our study reveals a new role for Pml in vivo during neurodevelopment. We show for the first time, to the best of our knowledge, that Pml is expressed in NPCs of the ventricular zone and is excluded from both early-born and mature neurons. Few other growth suppressors show such a restricted pattern of expression 45, 46 . For example, among Cdk inhibitors, Ink4c is the only family member whose expression is confined to NPCs in the ventricular zone 45 . Our results indicate that a loss of Pml leads to an increased number of proliferating NPCs and a defective exit from cell cycle without any substantial effect on programmed cell death, at least at early stages of corticogenesis. It is still unclear whether this is a result of changes in the length of specific cell-cycle phases. In this regard, it would be interesting to determine whether Pml -/-NPCs display alterations in G1, as an increase in the duration of the G1 phase is believed to act as a neurogenic switch 47 .
Finally, Pml loss appeared to affect the composition of the different NPCs subtypes, as more Pax6-positive radial glial cells (RGCs) and less basal Tbr2-positive progenitors (basally located intermediate progenitors) were found in the Pml -/-developing neocortex. Notably, a reduction in basally located intermediate progenitors has recently been shown to affect neurogenesis and cortex size [20] [21] [22] . Indeed, Pml loss impaired differentiation in the developing neocortex and led to a reduction in cortical thickness. However, as in basally located intermediate progenitor-deficient animals [20] [21] [22] , the layered structure of the cortex was maintained, thus indicating that specification and migration of neurons are not altered in Pml null cortices. Finally, in adult Pml -/-mice, the changes in size of the cerebral cortex were not as prominent, thus indicating a degree of postnatal compensation. Nonetheless, it is plausible that even more subtle neurodevelopmental defects could impair neuronal function in the adult animal and/or affect cognitive/ learning capacity.
Pml controls PP1a-mediated dephosphorylation of pRb
The effect of Pml loss on the proliferation of NPCs prompted us to test whether it could control the function of essential cell-cycle regulators. One of the potential targets was pRb, as it has been shown to control neurogenesis 28, [30] [31] [32] 34, 35 and to associate with Pml in non-neuronal cells 6, [28] [29] [30] . We found that Pml interacted and partially colocalized with pRb. In contrast, pRb was delocalized and hyperphosphorylated in Pml-deficient NPCs. The main pRb phosphatase is PP1a, which counteracts the inhibitory effect of Cdks 38, 39 . PP1a itself is inhibited by Cdk-dependent phosphorylation, thus adding a further level of regulation 48 . Moreover, PP1a induces G1 arrest in a strictly pRbdependent fashion 49 . During neurodevelopment, PP1a is controlled by the protein phosphatase and actin regulator 4 (Phactr4). As a result, the function of both PP1a and pRb is impaired in Phactr4 -/-embryos, leading to enhanced proliferation and defects in neuronal tube and optic fissure closure 40 . We found that Pml interacts and partially colocalizes with both PP1a and pRb in Pml-NBs, and Pml inactivation caused a change in the subcellular distribution of PP1a. Notably, Pml has been shown to control the activity of another phosphatase, PP2a, by regulating its localization to Pml-NBs 11 . It is therefore conceivable that Pml can protect both pRb and PP1a from Cdk-mediated phosphorylation by inducing their targeting to the Pml-NB. In addition, Pml may block PP1a from interacting with its nuclear inhibitors 50 . Finally, a Sumoylation-defective mutant of Pml, which is unable to form Pml-NBs, did not rescue pRb/PP1a localization in Pml -/-NPCs and failed to correct proliferation and differentiation defects.
Overall, our findings provide evidence for a previously unknown role of Pml in regulating cell fate in the developing mouse brain. More generally, our work shows that an increased number of NPCs in the developing neocortex does not necessarily result in augmented neurogenesis, but instead can lead to impaired differentiation and, in turn, to a decrease in cortex size. Finally, this study, together with the reported loss of Pml expression in human brain tumors 9 , opens up the possibility that alterations of Pml function may be involved in the onset of neoplastic disorders originating from the neuroepithelial compartment of the nervous system.
METHODS
Animals.
The Pml -/-mice were a generous gift from P.P. Pandolfi (Beth Israel Deaconess Cancer Center). Mice were backcrossed to the sv129 S2 strain for eight generations. Mice were bred and subjected to listed procedures under the Project License no. 80-2085, released from the Home Office.
antibody (in blocking solution), washed three times wash with 1Â PBS, and counterstained with DAPI and mounted for confocal microscopy. For triplestaining experiments, all immunofluorescence steps were performed using 5% bovine serum albumin (vol/vol) as a blocking reagent. Two different images of each section or cortical cells were taken and the number of cells labeled was counted (n ¼ 3 Pml null compared to n ¼ 3 control littermates).
BrdU labeling. Pregnant females were injected intraperitoneally at E15 for 1 h with 50 mg per g of body weight bromodeoxyuridine (BrdU). The females were culled 1 h later and the embryos were removed, fixed in 4% paraformaldehyde and embedded in paraffin. Sections were stained with antibody to BrdUfluorescin isothiocyanate (FITC). The number of BrdU-labeled cells was determined by counting BrdU+ cells from two confocal microscopy images of corresponding sections from 3 independent experiments (n ¼ 3 Pml null compared to n ¼ 3 control littermates).
For the cell-cycle exit experiment, pregnant females were injected at E14 with BrdU as described above for 24 h, culled and the embryos were removed, fixed in 4% paraformaldehyde and embedded in paraffin for sectioning. The sections were co-stained with antibodies to BrdU-FITC and Ki67. The cells that were counted in this experiment were the ones that exited the cell cycle (BrdU positive only) and were localized in the intermediate zone after radial migration. The cells that were still proliferating or remained in the cell cycle were BrdU and Ki67 positive and were localized in the ventricular zone.
Immunoblotting and immunoprecipitation. For immunoblotting, cortical neurospheres were collected, washed with 1Â PBS, lysed in a 1Â solution containing 50 mM Tris-HCl (pH 6.8), 100 mM dithiothreitol, 2% SDS (wt/ vol), 0.1% bromophenol blue (wt/vol) and 10% glycerol (vol/vol), and loaded on Tris/glycine SDS-polyacrylamide gels. For immunoprecipitation, the cortical cells were lysed in immunoprecipitation buffer (0.05 M Tris pH 7.4, 0.15 M NaCl, 0.5% Triton X-100, 0.001 M EDTA). The extracts were pre-cleared for 1 h at 4 1C using Protein G Plus-Agarose beads (IP08, Calbiochem) and antibody to IgG2b (Dako). For the antibody binding, antibody to Pml was incubated with agarose beads for 2 h in immunoprecipitation buffer before adding the pre-cleared extracts for overnight immunoprecipitation.
Cortical cell culture. Cortical cultures were prepared using reagents from Stem Cell Technologies and following the manufacturer's protocol and previously reported protocols 25, 26 . For the neurospheres cultures, the cortical cells were plated at clonal density (20 Â 10 3 cells ml -1 in 24-well plates) in complete Neurocult neural stem cell proliferation medium containing 10 ng ml -1 bFGF (Peprotech) and cultured for 10 DIV. For the differentiation assay, single-cell suspensions of cortical cells were plated at 5 Â 10 5 cells per well on poly-L-ornithine glass coverslips in complete Neurocult neural stem cell differentiation media. At 5 DIV, cells were fixed in 4% paraformaldehyde and analyzed for expression of the progenitor marker Nestin and the neuronal marker MAP2 by immunofluorescence. At 10 DIV cells were stained with antibodies to MBP and GFAP, which are markers for oligodendrocytes and astrocytes, respectively 23 , and to Nestin. The PP1a inhibitor (InSolution Tautomycetin, S. greseochrogenes; cat no. 580550, Calbiochem) was added to the neurospheres culture (5 mM) for 5.5 h.
Retroviral expression of Pml. Pml isoform V cDNA (kind gift from D. Grimwade, Kings College London) was cloned into the EcoRI site of pBabePuro (pBabe). A PCR-amplified fragment containing the PmlI-specific C terminus was cloned into the MluI/SalI sites of PmlV-pBabe to obtain PmlIpBabe. The PmlI mutant lacking Pml's three Sumoylation sites (DSumo1-PmlIpBabe) was generated by site-directed mutagenesis. Cortical cells were infected with high-titer pBabe, pBabe-PmlI or DSumo1-PmlI-pBabe retroviral supernatants and selected in puromycin (Sigma) for 48 h.
Statistical analysis. All statistical analyses were performed using unpaired twotailed t tests (AbiPrism).
Note: Supplementary information is available on the Nature Neuroscience website.
